Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of “Hold” by Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have been assigned an average rating of “Hold” from the eleven research firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $182.63.

A number of research firms have weighed in on TFX. Morgan Stanley reduced their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and dropped their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th.

Hedge Funds Weigh In On Teleflex

A number of institutional investors and hedge funds have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. raised its stake in Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock worth $1,098,693,000 after acquiring an additional 261,279 shares during the period. Janus Henderson Group PLC raised its stake in Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp raised its stake in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares during the period. Geode Capital Management LLC raised its stake in Teleflex by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock worth $202,161,000 after acquiring an additional 8,307 shares during the period. Finally, Cooke & Bieler LP raised its stake in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock worth $191,962,000 after acquiring an additional 195,150 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 1.1 %

NYSE:TFX opened at $137.79 on Monday. The firm has a market cap of $6.39 billion, a P/E ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex has a fifty-two week low of $128.55 and a fifty-two week high of $249.90. The firm has a 50-day simple moving average of $166.99 and a two-hundred day simple moving average of $197.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Analysts predict that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.